The clinical significance of aspirin resistance in patients with chest pain

Clinical Cardiology

Volumn 33, Issue 3, 2010, Pages

  Aydinalp, Alp ^a   Atar, Ilyas ^a   Gulmez, Oyku ^a   Atar, Asli ^a   Acikel, Sadik ^a   Bozbas, Huseyin ^a   Ozgul, Aliseydi ^a   Ertan, Cagatay ^a   Ozin, Bulent ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STABLE ANGINA PECTORIS; THORAX PAIN; THROMBOCYTE COUNT; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANALYSIS OF VARIANCE; ASPIRIN; BIOMARKERS, PHARMACOLOGICAL; BLOOD PLATELETS; CHEST PAIN; COLLAGEN; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; EPINEPHRINE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77949760918     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20539     Document Type: Article

References (13)

1. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med. 1989;321:129-135.
2. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptoknase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
4. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-STelevationMI: amethod for prognostication and therapeutic decision making. JAMA. 2000;284:835-842.
5. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227-1234.
6. Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol. 2005;46:1705-1709.
7. Sane DC, McKee SA, Malinin AI, Serebruany VL. Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin. Am J Cardiol. 2002;90:893-895.
8. Hovens MM, Snoep JD, Eikenboom JC, van der Bom JG, Mertens BJ, Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J. 2007;153:175-181.
9. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 2008;336:195-198.
10. Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinicalmanagement and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38:2114-2130.
11. Poulsen TS, Jørgensen B, Korsholm L, Bjørn Licht P, Haghfelt T, Mickley H. Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction. Thromb Res. 2007;119:555-562.
12. Hobikoglu GF, Norgaz T, Aksu H, et al. High frequency of aspirin resistance in patients with acute coronary syndrome. Tohoku J Exp Med. 2005;207:59-64.
13. Tran HA, Anand SS, Hankey GJ, Eikelboom JW. Aspirin resistance. Thromb Res. 2007;120:337-346.